Enhanced cerebral ischemic lesions after two-vein occlusion in diabetic rats

Brain Research

Volumn 1309, Issue , 2010, Pages 126-135

  Wajima, Daisuke ^a   Nakamura, Mitsutoshi ^a   Horiuchi, Kaoru ^a   Miyake, Hitoshi ^a   Takeshima, Yasuhiro ^a   Tamura, Kentaro ^a   Motoyama, Yasushi ^a   Konishi, Noboru ^a   Nakase, Hiroyuki ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Diabetes; OLETF rats; Two vein occlusion; Venous infarction

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL MODEL; BLOOD VESSEL WALL; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VEIN; CELL DEATH; CONTROLLED STUDY; DIABETES MELLITUS; MALE; NICK END LABELING; NONHUMAN; PATHOGENESIS; PHOTOCHEMISTRY; PRIORITY JOURNAL; RAT; RAT STRAIN; TWO VEIN OCCLUSION; VEIN OCCLUSION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; ARTERIOLES; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL DEATH; CEREBRAL VEINS; CEREBROVASCULAR CIRCULATION; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; FIBROSIS; GENETIC PREDISPOSITION TO DISEASE; IN SITU NICK-END LABELING; PHOTIC STIMULATION; PHOTOCHEMISTRY; RATS; RATS, INBRED OLETF; ROSE BENGAL; VENOUS THROMBOSIS; VENULES;

ANIMALIA; RATTUS;

EID: 72049131525     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.10.061     Document Type: Article

References (53)

1. Abbott R.D., Donahue R.P., MacMahon S.W., Reed D.M., and Yano K. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 257 (1987) 949-952
2. Akishita M., Iwai M., Wu L., Zhang L., Ouchi Y., Dzau V.J., and Horiuchi M. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 102 (2000) 1684-1689
3. Arrick D.M., Sharpe G.M., Sun H., and Mayhan W.G. Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase. Microvasc. Res. 73 (2007) 1-6
4. Barnes A.J., Locke P., Scudder P.R., Dormandy T.L., Dormandy J.A., and Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease. Lancet 2 (1977) 789-791
5. Bennett M.A., Watt P.A., and Thurston H. Impaired endothelium-dependent relaxation in two-kidney, one clip Goldblatt hypertension: effect of vasoconstrictor prostanoids. J. Hypertens. Suppl. 11 (1993) S134-135
6. Britton M., Rafols J., Alousi S., and Dunbar J.C. The effects of middle cerebral artery occlusion on central nervous system apoptotic events in normal and diabetic rats. Int. J. Exp. Diabesity Res. 4 (2003) 13-20
7. Brown M.M., and Marshall J. Regulation of cerebral blood flow in response to changes in blood viscosity. Lancet 1 (1985) 604-609
8. Cooper M.E., Rumble J., Komers R., Du H.C., Jandeleit K., and Chou S.T. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes 43 (1994) 1221-1228
9. Cooper M.E., Gilbert R.E., and Jerums G. Diabetic vascular complications. Clin. Exp. Pharmacol. Physiol. 24 (1997) 770-775
10. D'Agostino R.B., Wolf P.A., Belanger A.J., and Kannel W.B. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25 (1994) 40-43
11. Didion S.P., Lynch C.M., Baumbach G.L., and Faraci F.M. Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes. Stroke 36 (2005) 342-347
12. Duckrow R.B., Beard D.C., and Brennan R.W. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18 (1987) 52-58
13. Dumont A.S., Dumont R.J., McNeill J.H., Kassell N.F., Sutherland G.R., and Verma S. Chronic endothelin antagonism restores cerebrovascular function in diabetes. Neurosurgery 52 (2003) 653-660 discussion 659-660
14. Friedland R.P., and Grant S. Hematocrit, viscosity and cerebral blood flow. Am. Heart J. 97 (1979) 404-405
15. Fujita Y., Lin J.X., Takahashi R., and Tomimoto H. Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats. Brain Res. 1203 (2008) 170-176
16. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
17. Gilbert R.E., Rumble J.R., Cao Z., Cox A.J., van Eeden P., Allen T.J., Kelly D.J., and Cooper M.E. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circ. Res. 86 (2000) 158-165
18. Harris A.K., Hutchinson J.R., Sachidanandam K., Johnson M.H., Dorrance A.M., Stepp D.W., Fagan S.C., and Ergul A. Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 54 (2005) 2638-2644
19. Harris A.K., Elgebaly M.M., Li W., Sachidanandam K., and Ergul A. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol 294 (2008) R1213-1219
20. Heimann A., Takeshima T., Alessandri B., Noppens R., and Kempski O. Effects of hypertonic/hyperoncotic treatment after rat cortical vein occlusion. Crit. Care Med. 31 (2003) 2495-2501
21. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
22. Hosomi N., Noma T., Ohyama H., Takahashi T., and Kohno M. Vascular proliferation and transforming growth factor-beta expression in pre-and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Atherosclerosis 162 (2002) 69-76
23. Huang N.C., Wei J., and Quast M.J. A comparison of the early development of ischemic brain damage in normoglycemic and hyperglycemic rats using magnetic resonance imaging. Exp. Brain Res. 109 (1996) 33-42
24. Intengan H.D., and Schiffrin E.L. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 36 (2000) 312-318
25. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., and Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992) 1422-1428
26. Kempski O., Seiwert T., Otsuka H., Heimann A., and Nakase H. Modelling of the ischemic penumbra. Acta Neurochir. Suppl. 73 (1999) 41-44
27. Kimura R., Nakase H., Sakaki T., Taoka T., and Tsuji T. Vasogenic edema and VEGF expression in a rat two-vein occlusion model. Acta Neurochir. Suppl. 86 (2003) 213-217
28. Kissela B.M., Khoury J., Kleindorfer D., Woo D., Schneider A., Alwell K., Miller R., Ewing I., Moomaw C.J., Szaflarski J.P., Gebel J., Shukla R., and Broderick J.P. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28 (2005) 355-359
29. Kuusisto J., Mykkanen L., Pyorala K., and Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25 (1994) 1157-1164
30. Li Z.G., Britton M., Sima A.A., and Dunbar J.C. Diabetes enhances apoptosis induced by cerebral ischemia. Life Sci. 76 (2004) 249-262
31. Luscher T.F., Boulanger C.M., Dohi Y., and Yang Z.H. Endothelium-derived contracting factors. Hypertension 19 (1992) 117-130
32. Mayhan W.G. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 256 (1989) H621-625
33. McMillan D.E., Utterback N.G., and La Puma J. Reduced erythrocyte deformability in diabetes. Diabetes 27 (1978) 895-901
34. Mizushige K., Yao L., Noma T., Kiyomoto H., Yu Y., Hosomi N., Ohmori K., and Matsuo H. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101 (2000) 899-907
35. Nakagawa I., Alessandri B., Heimann A., and Kempski O. MitoKATP-channel opener protects against neuronal death in rat venous ischemia. Neurosurgery 57 (2005) 334-340 discussion 334-340
36. Nakase H., Heimann A., and Kempski O. Local cerebral blood flow in a rat cortical vein occlusion model. J. Cereb. Blood Flow Metab. 16 (1996) 720-728
37. Nishioka T., Nakase H., Nakamura M., Konishi N., and Sakaki T. Sequential and spatial profiles of apoptosis in ischemic penumbra after two-vein occlusion in rats. J. Neurosurg. 104 (2006) 938-944
38. Noma T., Mizushige K., Yao L., Yu Y., Kiyomoto H., Hosomi N., Kimura S., Abe Y., Ohmori K., and Matsuo H. Alteration in aortic wall stiffness and accumulation of collagen during the prediabetic stage of type II diabetes mellitus in rats. Jpn. Circ. J. 63 (1999) 988-993
39. Otsuka H., Nakase H., Nagata K., Ueda K., Kempski O., and Sakaki T. Effect of age on cerebral venous circulation disturbances in the rat. J. Neurosurg. 93 (2000) 298-304
40. Porta M., La Selva M., Molinatti P., and Molinatti G.M. Endothelial cell function in diabetic microangiopathy. Diabetologia 30 (1987) 601-609
41. Rodriguez B.L., D'Agostino R., Abbott R.D., Kagan A., Burchfiel C.M., Yano K., Ross G.W., Silbershatz H., Higgins M.W., Popper J., Wolf P.A., and Curb J.D. Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: a comparison of incidence and risk factor effects. Stroke 33 (2002) 230-236
42. Rubin M.J., and Bohlen H.G. Cerebral vascular autoregulation of blood flow and tissue PO2 in diabetic rats. Am. J. Physiol. 249 (1985) H540-H546
43. Rumble J.R., Cooper M.E., Soulis T., Cox A., Wu L., Youssef S., Jasik M., Jerums G., and Gilbert R.E. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J. Clin. Invest. 99 (1997) 1016-1027
44. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
45. Thomas D.J., Marshall J., Russell R.W., Wetherley-Mein G., du Boulay G.H., Pearson T.C., Symon L., and Zilkha E. Effect of haematocrit on cerebral blood-flow in man. Lancet 2 (1977) 941-943
46. Trauernicht A.K., Sun H., Patel K.P., and Mayhan W.G. Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats. Stroke 34 (2003) 2698-2703
47. Tuomilehto J., Rastenyte D., Jousilahti P., Sarti C., and Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke 27 (1996) 210-215
48. Vinik A., and Flemmer M. Diabetes and macrovascular disease. J. Diabet. Complicat. 16 (2002) 235-245
49. Wautier J.L., Paton R.C., Wautier M.P., Pintigny D., Abadie E., Passa P., and Caen J.P. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N. Engl. J. Med. 305 (1981) 237-242
50. Whisnant J.P. Modeling of risk factors for ischemic stroke. The Willis Lecture. Stroke 28 (1997) 1840-1844
51. Yagi K., Kim S., Wanibuchi H., Yamashita T., Yamamura Y., and Iwao H. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension 29 (1997) 728-735
52. Yao H., Takasawa R., Fukuda K., Shiokawa D., Sadanaga-Akiyoshi F., Ibayashi S., Tanuma S., and Uchimura H. DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats. Brain Res. Mol. Brain Res. 91 (2001) 112-118
53. Zimmermann P.A., Knot H.J., Stevenson A.S., and Nelson M.T. Increased myogenic tone and diminished responsiveness to ATP-sensitive K+ channel openers in cerebral arteries from diabetic rats. Circ. Res. 81 (1997) 996-1004